by Mastopexy, also known as breast lift surgery, is a cosmetic surgical procedure that involves the lifting and reshaping of sagging breasts through the removal of excess skin and remodeling of the breast tissue to create a youthful breast contour. The procedure is generally performed in cases where the breasts have lost their elasticity and firmness due to major weight changes, pregnancy, nursing, or the natural aging process. Mastopexy offers women an effective method to restore the firm, lifted appearance of their breasts.
The Global Mastopexy Market is estimated to be valued at US$ 2.39 BN in 2024 and is expected to exhibit a CAGR of 6.3% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the global mastopexy market are Allergan, Sientra, Integra, Polytech, Johnson & Johnson, Cynosure, SOLTA Medical, Syneron Medical, Galderma and Lumenis.
The key opportunities in the Global Mastopexy Market Size include increasing uptake of minimally invasive breast procedures and the availability of newer techniques that offer shorter recovery times and better cosmetic outcomes. Also, rising awareness about breast aesthetic surgeries through social media is propelling the mastopexy market growth.
Technological advancements such as the advent of advanced local anesthesia protocols, radiofrequency-assisted liposuction techniques, selective cord ligation, and triple-V mastopexy have made breast lift surgery safer and more effective with improved cosmetic results and reduced procedural time.
Market Drivers
One of the key drivers for the global mastopexy market is the increasing emphasis on physical appearance and rising social acceptance of cosmetic procedures. Additionally, the growing prevalence of breast ptosis or sagging among women due to factors such as rapid weight fluctuations, pregnancy, and aging is another major factor fueling the demand for mastopexy procedures. Furthermore, improving healthcare infrastructure and rapid adoption of advanced medical technologies in emerging markets is expected to boost the mastopexy market growth during the forecast period.
Current challenges in Global Mastopexy Market:
– The market is facing challenges due to reduced reimbursements for breast surgeries. Various governments across countries have reduced reimbursements on cosmetic procedures, thereby limiting market growth prospects.
– Despite the positive growth of the market, concerns regarding the safety of silicone breast implants may hamper the market demand. Silicone gel and saline-filled breast implants were linked to breast implant associated anaplastic large cell lymphoma (BIA-ALCL) which is a rare type of non-Hodgkin’s lymphoma (cancer).
SWOT Analysis
Strength: It is a minimally invasive procedure for breast lift with shorter recovery time and less scarring compared to traditional breast lifts. This boosts its acceptance rate.
Weakness: Risk of complications including wound separation, infection, bleeding and numbness. Expensive nature of the procedure restricts its reach.
Opportunity: Rising obesity rates and changing lifestyle leading to sagging of breasts creates demand. Growing medical tourism in developing nations acts as an opportunity.
Threats: Stringent regulatory approvals and safety concerns over implants limits scope. availability of alternative non-surgical procedures poses a threat.
The United States accounts for the largest market share in Global Mastopexy Market in terms of value due to factors such as favorable reimbursement policies and rising number of obese population in the country.
Asia Pacific region is expected to witness the fastest growth during the forecast period due to factors such as growing medical tourism, rising disposable incomes and increasing preference for aesthetic procedures in major Asia Pacific countries including China, India and South Korea.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
